Comparative analysis of the role of small G proteins in cell migration and cell death: Cytoprotective and promigratory effects of RalA

Experimental Cell Research

Volumn 317, Issue 14, 2011, Pages 2007-2018

  Jeon, Hyejin ^a   Zheng, Long Tai ^a,f   Lee, Shinrye ^a   Lee, Won Ha ^b   Park, Nammi ^c   Park, Jae Yong ^c   Heo, Won Do ^d   Lee, Myung Shik ^e   Suk, Kyoungho ^a  

^a Kyungpook National University School of Medicine   (South Korea)

^b Kyungpook National University   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

^d Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^e Sungkyunkwan University School of Medicine   (South Korea)

^f SOOCHOW UNIVERSITY   (China)

Author keywords

Apoptosis; Cell death; Cell migration; RalA; Small G protein

Indexed keywords

ANTINEOPLASTIC AGENT; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; RALA PROTEIN; RAN PROTEIN; RAS PROTEIN; RHO FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROTECTION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STRESS FIBER;

EID: 79960102252     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2011.05.021     Document Type: Article

References (50)

1. Flanagan K., Kaufman H.L. Chemokines in tumor immunotherapy. Front. Biosci. 2006, 11:1024-1030.
2. Gialeli C., Theocharis A.D., Karamanos N.K. Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting. FEBS J. 2011, 278:16-27.
3. Mackay C.R. Moving targets: cell migration inhibitors as new anti-inflammatory therapies. Nat. Immunol. 2008, 9:988-998.
4. Luster A.D., Alon R., von Andrian U.H. Immune cell migration in inflammation: present and future therapeutic targets. Nat. Immunol. 2005, 6:1182-1190.
5. Ley K., Laudanna C., Cybulsky M.I., Nourshargh S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7:678-689.
6. Coghlin C., Murray G.I. Current and emerging concepts in tumour metastasis. J. Pathol. 2010, 222:1-15.
7. Madsen C.D., Sahai E. Cancer dissemination-lessons from leukocytes. Dev. Cell 2010, 19:13-26.
8. Hickman J.A. Apoptosis and tumourigenesis. Curr. Opin. Genet. Dev. 2002, 12:67-72.
9. Schulze-Bergkamen H., Krammer P.H. Apoptosis in cancer-implications for therapy. Semin. Oncol. 2004, 31:90-119.
10. Bunnell C.A., Shulman L.N. Will we be able to care for cancer patients in the future?. Oncology (Williston Park) 2010, 24:1343-1348.
11. Takai Y., Sasaki T., Matozaki T. Small GTP-binding proteins. Physiol. Rev. 2001, 81:153-208.
12. Goldfinger L.E. Choose your own path: specificity in Ras GTPase signaling. Mol. Biosyst. 2008, 4:293-299.
13. Reuther G.W., Der C.J. The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr. Opin. Cell Biol. 2000, 12:157-165.
14. Wennerberg K., Rossman K.L., Der C.J. The Ras superfamily at a glance. J. Cell Sci. 2005, 118:843-846.
15. Aznar S., Lacal J.C. Rho signals to cell growth and apoptosis. Cancer Lett. 2001, 165:1-10.
16. Sahai E., Marshall C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2002, 2:133-142.
17. Gomez J., Martinez A.C., Gonzalez A., Rebollo A. Dual role of Ras and Rho proteins: at the cutting edge of life and death. Immunol. Cell Biol. 1998, 76:125-134.
18. Fritz G., Kaina B. Rho GTPases: promising cellular targets for novel anticancer drugs. Curr. Cancer Drug Targets 2006, 6:1-14.
19. Aznar S., Fernandez-Valeron P., Espina C., Lacal J.C. Rho GTPases: potential candidates for anticancer therapy. Cancer Lett. 2004, 206:181-191.
20. Linseman D.A., Loucks F.A. Diverse roles of Rho family GTPases in neuronal development, survival, and death. Front. Biosci. 2008, 13:657-676.
21. Cox A.D., Der C.J. The dark side of Ras: regulation of apoptosis. Oncogene 2003, 22:8999-9006.
22. Feig L.A., Buchsbaum R.J. Cell signaling: life or death decisions of ras proteins. Curr. Biol. 2002, 12:R259-261.
23. Khokhlatchev A., Rabizadeh S., Xavier R., Nedwidek M., Chen T., Zhang X.F., Seed B., Avruch J. Identification of a novel Ras-regulated proapoptotic pathway. Curr. Biol. 2002, 12:253-265.
24. Saporita A.J., Maggi L.B., Apicelli A.J., Weber J.D. Therapeutic targets in the ARF tumor suppressor pathway. Curr. Med. Chem. 2007, 14:1815-1827.
25. Kowluru A., Morgan N.G. GTP-binding proteins in cell survival and demise: the emerging picture in the pancreatic beta-cell. Biochem. Pharmacol. 2002, 63:1027-1035.
26. Heo W.D., Meyer T. Switch-of-function mutants based on morphology classification of Ras superfamily small GTPases. Cell 2003, 113:315-328.
27. Arvidsson S., Kwasniewski M., Riano-Pachon D.M., Mueller-Roeber B. QuantPrime-a flexible tool for reliable high-throughput primer design for quantitative PCR. BMC Bioinforma. 2008, 9:465.
28. Liang C.C., Park A.Y., Guan J.L. In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro. Nat. Protoc. 2007, 2:329-333.
29. Bassi R., Giussani P., Anelli V., Colleoni T., Pedrazzi M., Patrone M., Viani P., Sparatore B., Melloni E., Riboni L. HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration. J. Neurooncol. 2008, 87:23-33.
30. Seo M., Lee W.H., Suk K. Identification of novel cell migration-promoting genes by a functional genetic screen. FASEB J. 2010, 24:464-478.
31. Michaelson D., Silletti J., Murphy G., D'Eustachio P., Rush M., Philips M.R. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 2001, 152:111-126.
32. Gottlieb R.A., Nordberg J., Skowronski E., Babior B.M. Apoptosis induced in Jurkat cells by several agents is preceded by intracellular acidification. Proc. Nat. Acad. Sci. U.S.A. 1996, 93:654-658.
33. Tang D., Lahti J.M., Grenet J., Kidd V.J. Cycloheximide-induced T-cell death is mediated by a Fas-associated death domain-dependent mechanism. J. Biol. Chem. 1999, 274:7245-7252.
34. Wang H.L., Akinci I.O., Baker C.M., Urich D., Bellmeyer A., Jain M., Chandel N.S., Mutlu G.M., Budinger G.R. The intrinsic apoptotic pathway is required for lipopolysaccharide-induced lung endothelial cell death. J. Immunol. 2007, 179:1834-1841.
35. Galea-Lauri J., Richardson A.J., Latchman D.S., Katz D.R. Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide: a possible role in immunopathology. J. Immunol. 1996, 157:4109-4118.
36. Liu T., Schneider R.A., Shah V., Huang Y., Likhotvorik R.I., Keshvara L., Hoyt D.G. Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells. J. Inflamm. (Lond.) 2009, 6:20.
37. Perona R., Sanchez-Perez I. Signalling pathways involved in clinical responses to chemotherapy. Clin. Transl. Oncol. 2007, 9:625-633.
38. Manning B.D., Cantley L.C. AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
39. Kim E.K., Choi E.J. Pathological roles of MAPK signaling pathways in human diseases. Biochim. Biophys. Acta 2010, 1802:396-405.
40. Wagner E.F., Nebreda A.R. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat. Rev. Cancer 2009, 9:537-549.
41. Geest C.R., Coffer P.J. MAPK signaling pathways in the regulation of hematopoiesis. J. Leukoc. Biol. 2009, 86:237-250.
42. Shioda N., Han F., Fukunaga K. Role of Akt and ERK signaling in the neurogenesis following brain ischemia. Int. Rev. Neurobiol. 2009, 85:375-387.
43. Ohta Y., Suzuki N., Nakamura S., Hartwig J.H., Stossel T.P. The small GTPase RalA targets filamin to induce filopodia. Proc. Nat. Acad. Sci. U.S.A. 1999, 96:2122-2128.
44. van Dam E.M., Robinson P.J. Ral: mediator of membrane trafficking. Int. J. Biochem. Cell Biol. 2006, 38:1841-1847.
45. Camonis J.H., White M.A. Ral GTPases: corrupting the exocyst in cancer cells. Trends Cell Biol. 2005, 15:327-332.
46. Bodemann B.O., White M.A. Ral GTPases and cancer: linchpin support of the tumorigenic platform. Nat. Rev. Cancer 2008, 8:133-140.
47. Matozaki T., Nakanishi H., Takai Y. Small G-protein networks: their crosstalk and signal cascades. Cell. Signal. 2000, 12:515-524.
48. Wang L., Zheng Y. Cell type-specific functions of Rho GTPases revealed by gene targeting in mice. Trends Cell Biol. 2007, 17:58-64.
49. Boulter E., Garcia-Mata R., Guilluy C., Dubash A., Rossi G., Brennwald P.J., Burridge K. Regulation of Rho GTPase crosstalk, degradation and activity by RhoGDI1. Nat. Cell Biol. 2010, 12:477-483.
50. Hallstrom T.C., Nevins J.R. Balancing the decision of cell proliferation and cell fate. Cell Cycle 2009, 8:532-535.